Edward Nirenberg on Nostr: Merck (who makes PCV21), has an interesting suggestion: serotype 4 of pneumococcal ...
Merck (who makes PCV21), has an interesting suggestion: serotype 4 of pneumococcal tends to be clustered, which suggests that selective implementation of PCV20 in those clusters may be worthwhile while also lowering the age recommendation to 50 for PCV21.
Published at
2024-06-27 19:55:22Event JSON
{
"id": "4e178f13a259b57c64a0572a4bff0b8867c08418b70d6a08b49c080ce91c33d2",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719518122,
"kind": 1,
"tags": [
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112690339695317746",
"activitypub"
]
],
"content": "Merck (who makes PCV21), has an interesting suggestion: serotype 4 of pneumococcal tends to be clustered, which suggests that selective implementation of PCV20 in those clusters may be worthwhile while also lowering the age recommendation to 50 for PCV21.",
"sig": "b01e0c2f9af04f3476c26326b6be5a188ab25768e73d546055ea3116527f3a01a0026df8634b9fe718ad66b5dfc8fbdc04dab878ce1c7eb46a3cd9a11b7fc4b3"
}
